Crossject (ALCJ) - Total Liabilities

Latest as of December 2025: €35.30 Million EUR ≈ $41.27 Million USD

Based on the latest financial reports, Crossject (ALCJ) has total liabilities worth €35.30 Million EUR (≈ $41.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Crossject's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Crossject - Total Liabilities Trend (2010–2025)

This chart illustrates how Crossject's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Crossject asset portfolio.

Crossject Competitors by Total Liabilities

The table below lists competitors of Crossject ranked by their total liabilities.

Company	Country	Total Liabilities
Tonymoly Co Ltd KO:214420	Korea	₩106.53 Billion
Many Peaks Minerals Ltd AU:MPK	Australia	AU$647.45K
Munsin Garment TWO:2916	Taiwan	NT$606.48 Million
Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust BK:AMATAR	Thailand	฿1.07 Billion
Greenheart Gold Inc. V:GHRT	Canada	CA$2.24 Million
Bioton S.A. WAR:BIO	Poland	zł170.59 Million
Cullman Bancorp Inc. NASDAQ:CULL	USA	$367.78 Million
Bflysoft Co. Ltd. KQ:148780	Korea	₩3.74 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Crossject's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Crossject to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-7.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Crossject's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Crossject (2010–2025)

The table below shows the annual total liabilities of Crossject from 2010 to 2025.

Year	Total Liabilities	Change
2025-12-31	€35.30 Million ≈ $41.27 Million	+3.10%
2024-12-31	€34.24 Million ≈ $40.03 Million	+0.97%
2023-12-31	€33.91 Million ≈ $39.64 Million	+12.38%
2022-12-31	€30.17 Million ≈ $35.28 Million	-18.46%
2021-12-31	€37.01 Million ≈ $43.26 Million	+6.58%
2020-12-31	€34.72 Million ≈ $40.59 Million	+61.63%
2019-12-31	€21.48 Million ≈ $25.11 Million	+16.08%
2018-12-31	€18.50 Million ≈ $21.63 Million	+59.11%
2017-12-31	€11.63 Million ≈ $13.60 Million	+46.01%
2016-12-31	€7.97 Million ≈ $9.31 Million	+56.75%
2015-12-31	€5.08 Million ≈ $5.94 Million	+30.64%
2014-12-31	€3.89 Million ≈ $4.55 Million	-17.28%
2013-12-31	€4.70 Million ≈ $5.50 Million	+4.54%
2012-12-31	€4.50 Million ≈ $5.26 Million	-10.71%
2011-12-31	€5.04 Million ≈ $5.89 Million	-54.46%
2010-12-31	€11.06 Million ≈ $12.93 Million	--

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$82.54 Million

€70.61 Million EUR

Market Cap Rank

#20031 Global

#304 in France

Share Price

€1.33

Change (1 day)

+0.61%

52-Week Range

€1.31 - €2.69

All Time High

€10.40